跳至主要内容
临床试验/DRKS00023623
DRKS00023623已完成不适用

Posttraumatc headache - pain related evoked potentials and conditioned pain modulation as possible biomarkers for the identification of risk patients - PTH-PREP

eurologische KlinikBG Universitätsklinikum Bergmannsheil gGmbH0 个研究点目标入组 46 人开始时间: 2020年11月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Inclusion criteria for patients:
  • - Acute or persistent headache resulting from a traumatic head injury
  • - The headache developed within 7 days of any of the following: the head injury, regaining consciousness after the head injury, discontinuation of medication that interferes with the ability to feel or report a headache after the head injury
  • - The headache is not better explained by another ICHD-3 diagnosis
  • Inclusion criteria for healthy control subjects:
  • - none of the exclusion criteria is met
  • - Present declaration of consent
  • - No abnormal result in the questionnaire or physical examination
  • - no use of drugs with peripheral or central nervous effects /side effect
  • - no neurological or psychiatric illness

排除标准

  • Exclusion criteria for patients:
  • - Age <18 years
  • - no declaration of consent
  • - Average pain intensity in the last 4 weeks <2 (NRS 0-10)
  • - Current pain intensity <2 (NRS 0-10)
  • - Insufficient knowledge of German or other communication problems
  • - Neuropathic pain syndromes
  • - Headache illness known before the accident
  • - Treatment with topical local anesthetics for <7 days in the last 6 weeks or for >7 days in the last 4 months
  • - Treatment with topical capsaicin in the past 6 months
  • - Epilepsy treated with anticonvulsants
  • - Psychiatric illness treated with anticonvulsants or antidepressants with a proven effect on neuropathic pain
  • - Other pain localization with a pain intensity =6 (NRS 0-10) on =15 days / month
  • - Other severe systemic or focal CNS affection
  • - Other central or peripheral neurological disorders
  • - peripheral arterial occlusive disease (except for stage Fontaine I)
  • - Serious cognitive or psychiatric impairment
  • Exclusion criteria for healthy control subjects:
  • - Age <18 years
  • - no declaration of consent
  • - Average pain intensity in the last 4 weeks> 2 (NRS 0-10)
  • - Current pain intensity >0 (NRS 0-10)
  • - Insufficient knowledge of German or other communication problems
  • - Neuropathies, radiculopathies, or nerve lesions
  • - Chronic pain syndromes
  • - Treatment with topical local anesthetics for the past 6 weeks
  • - Treatment with topical capsaicin in the past 6 months
  • - Epilepsy treated with anticonvulsants
  • - Psychiatric illness treated with anticonvulsants or antidepressants with a proven effect on neuropathic pain
  • - Other severe systemic or focal CNS affection
  • - Other central or peripheral neurological disorders
  • - peripheral arterial occlusive disease (except for stage Fontaine I)
  • - Serious cognitive or psychiatric impairment

研究者

发起方
eurologische KlinikBG Universitätsklinikum Bergmannsheil gGmbH

相似试验